Case Report: Neoadjuvant and Adjuvant Crizotinib Targeted Therapy in Stage IIIA-N2 ALK-Positive Non-Small-Cell Lung Cancer

The treatment of anaplastic lymphoma kinase (ALK)-positive locally advanced non-small-cell lung cancer (NSCLC) is challenging because there is no randomized controlled trial has been reported. The value of neoadjuvant and adjuvant targeted therapy remains unclear. Herein, we show that systemic treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiao-Hong, Zhan, Ze-Jiang, Qin, Yin-Yin, Jiang, Ju-Hong, Yin, Wei-Qiang, Zheng, Rong-Hui, Li, Shi-Yue, Zhou, Cheng-Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010235/
https://www.ncbi.nlm.nih.gov/pubmed/33816312
http://dx.doi.org/10.3389/fonc.2021.655856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010235/
https://www.ncbi.nlm.nih.gov/pubmed/33816312
http://dx.doi.org/10.3389/fonc.2021.655856

Ejemplares similares